Centiva Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,350
Closed -$257K 1779
2025
Q4
$257K Buy
+11,350
New +$247K ﹤0.01% 905
2025
Q1
Sell
-98,092
Closed -$1.19M 1696
2024
Q4
$1.19M Buy
+98,092
New +$1.28M 0.02% 489
2022
Q4
Sell
-56,144
Closed -$697K 1423
2022
Q3
$697K Sell
56,144
-10,122
-15% -$177K 0.01% 762
2022
Q2
$1.3M Buy
+66,266
New +$1.57M 0.03% 501
2021
Q3
Sell
-6,661
Closed -$231K 1367
2021
Q2
$231K Buy
+6,661
New +$220K 0.01% 1153
2020
Q2
Sell
-11,025
Closed -$247K 703
2020
Q1
$247K Buy
+11,025
New +$302K 0.01% 415
2019
Q4
Sell
-19,660
Closed -$523K 836
2019
Q3
$523K Buy
+19,660
New +$590K 0.03% 319
2019
Q2
Sell
-79,750
Closed -$2.56M 459
2019
Q1
$2.56M Buy
+79,750
New +$2.45M 0.17% 95

Other funds holding ELAN

Centiva Capital's ELAN Position: Q1 2026 in Review

Centiva Capital sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 11,350 shares — an estimated $257K sold.

Centiva Capital first reported a position in ELAN in Q1 2019 and held it in 8 quarters. The position peaked at $2.56M in Q1 2019. 518 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Centiva Capital reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 11,350 Elanco Animal Health shares in Q1 2026, an estimated $257K.
  • Centiva Capital first reported a position in Elanco Animal Health in Q1 2019 and held it in 8 quarters.
  • Centiva Capital's Elanco Animal Health position peaked at $2.56M in Q1 2019.
  • 518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.